Monthly Archives: August 2016

SHAREHOLDER ALERT: Class Action Lawsuit Filed Against Corrections Corporation of America – CXW

RADNOR, PA / ACCESSWIRE / August 29, 2016 / The law firm of Kessler Topaz Meltzer & Check, LLP alerts Corrections Corporation of America (NYSE: CXW) (“CCA” or the “Company”) shareholders that a class action lawsuit has been filed in the Middle District of Tennessee on behalf of purchasers of the Company’s securities between February
27, 2012 and August 17, 2016, inclusive (the “Class Period”).

Shareholders who wish to discuss this action and their legal options are encouraged to contact Kessler Topaz Meltzer & Check, LLP (Darren J. Check, Esq., D. Seamus Kaskela, Esq. or Adrienne O. Bell, Esq.) at (888) 299-7706 or at info@ktmc.com.

CCA shareholders who purchased securities during the Class Period may, no later than October 24, 2016, seek to be appointed as a lead plaintiff of the class. For additional information please visit https://www.ktmc.com/new-cases/corrections-corporation-of-america#join.

CCA, together with its subsidiaries, owns, operates, and manages private prisons and other correctional facilities in the United States, and provides inmate residential and prisoner transportation services for governmental agencies.

The complaint alleges that CCA and certain of its executive officers made a series of false and misleading statements and/or failed to disclose to investors during the Class Period that: (i) CCA’s facilities lacked adequate safety and security standards and were less efficient at offering correctional services than the Federal Bureau of Prisons’ (“BOP”) facilities; (ii) CCA’s rehabilitative services for inmates were less effective than those provided by BOP; (iii) consequently, the U.S. Department of Justice (“DOJ”) was unlikely to renew and/or extend its contracts with CCA; and (iv) as a result of the foregoing, CCA’s public statements were materially false and misleading at all relevant times.

As detailed in the complaint, on August 18, 2016, Deputy Attorney General Sally Yates announced the DOJ’s decision to end its use of private prisons, including those operated by CCA, after officials concluded that the facilities are both less safe and less effective at providing correctional services than those run by the federal government.

Following this news, shares of the Company’s stock declined $9.65 per share, or over 35%, to close on August 18, 2016 at $17.57 per share, on unusually heavy trading volume.

CCA shareholders may, no
later than October 24, 2016, petition the Court to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class in the action. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. For additional information please visit https://www.ktmc.com/new-cases/corrections-corporation-of-america#join.

Kessler Topaz Meltzer & Check prosecutes class actions in state and federal courts throughout the country. Kessler Topaz Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check. For more information about Kessler Topaz Meltzer & Check, or for additional information about participating in this action, please visit www.ktmc.com.

CONTACT:

Kessler Topaz Meltzer & Check, LLP
Darren J. Check, Esq.
D. Seamus Kaskela, Esq.
Adrienne O. Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087
(888) 299-7706
(610) 667-7706
info@ktmc.com

SOURCE: Kessler Topaz Meltzer & Check, LLP

ReleaseID: 444265

Oxis Biotech’s TriKE Cancer-Fighting Technology Receives Key NIH Endorsement

LOS ANGELES, CA / ACCESSWIRE / August 29, 2016 / Oxis Biotech Inc., a wholly owned subsidiary of Oxis International Inc. (OTCQB: OXIS and Euronext Paris OXI.PA), announced today that its research partners at the University of Minnesota cancer center are collaborating with the National Institutes of Health to accelerate commercialization of their promising TriKE cancer-fighting platform.

The University of Minnesota is one of 14 high-impact research institutions across the country that are now in partnership with the NIH centers for commercialization (NCAI). The university was designated an NIH Research Evaluation and Commercialization Hub (REACH), a step that could boost efforts by Oxis and the university to commercialize new cancer therapies.

The University of Minnesota and Dr. Daniel A Vallera, Professor of Radiation Oncology at the University of Minnesota, were chosen for the award based on the TriKE platform because it’s an improvement over current technology and because of its prospects for success based on efficacy studies.

Applications for the REACH award were invited from the areas of therapeutics, preventatives, diagnostics, devices, and tools.

In July, Oxis announced that it had agreed to a major partnership with the University of Minnesota to develop and commercialize cancer therapies using TriKE technology developed by researchers at the university.

Anthony J. Cataldo, Chief Executive Officer of Oxis, said the NIH recognition is evidence that the company’s partnership with the University of Minnesota has significant potential to lead to breakthroughs in the treatment of cancer.

“The NIH REACH award for the University of Minnesota TriKE platform technology (OXS-3550) is further indication of the value and uniqueness of the TriKE platform,” Mr. Cataldo said.

“Dr. Dan Vallera and Dr. Jeff Miller have leveraged the funds provided from this award to create this new disruptive technology for off-the-shelf targeted immunotherapy. This next generation platform technology is exactly why Oxis is excited by our partnership with the University Of Minnesota.”

Oxis’ partnership with the university is part of a formula that has succeeded before. Mr. Cataldo used a similar research partnership to develop Lion Biotechnologies Inc. (LBIO) in 2011. That company now has a market capitalization of more than $500 million.

“When I created Lion Biotechnologies, Inc., I felt that the National Cancer Institute (NCI) cell therapy developed by Dr. Steven Rosenberg was the next wave of exciting disruptive technology, which proved to be true,” Mr. Cataldo said. “It is becoming clear that off-the-shelf targeted immunotherapy developed by Drs. Vallera and Miller will represent the next wave of excitement in the biotech community.”

Dr. Miller said there is tremendous potential for TriKE technology, which trains the body’s immune system to kill cancer cells while leaving healthy cells alone.

“We are now working with Oxis to go forward into FDA clinical trials to demonstrate TriKE efficacy and believe it can deliver an immune expansion signal directly to the cancer cell, diminishing drug-related toxicity, one of the biggest challenges facing biotech companies that have non targeted therapies,” Dr. Miller said.

The medical journal Science Translational Medicine recently highlighted TriKe research by the University of Minnesota’s Vallera and Miller.

Science Translational Medicine designated the research as an “Editors’ Choice,” and said, “TriKEs were superior in restoring potent antigen-specific NK cell responses against AML targets and mediated robust and specific NK cell proliferation.”

TriKE technology has several benefits compared to CAR-T therapy, which is very expensive and has been shown to carry significant side effects. Both Kite Pharma (Nasdaq:KITE) and Juno Therapeutics Inc. (Nasdaq:JUNO) have gained significant attention for their CAR-T efforts.

ABOUT OXIS INTERNATIONAL, INC. – Oxis International, Inc., through a wholly owned subsidiary, Oxis Biotech, Inc., develops innovative drugs focused on the treatment of cancer and other unmet medical needs. Oxis’ lead drug candidate, OXS-1550 (DT2219ARL) is a novel bispecific scFv recombinant fusion protein-drug conjugate composed of the variable regions of the heavy and light chains of anti-CD19 and anti-CD22 antibodies and a modified form of diphtheria toxin as its cytotoxic drug payload. OXS-1550 simultaneously targets cancer cells expressing the CD19 receptor or CD22 receptor or both receptors. When OXS-1550 binds to cancer cells, the cancer cells internalize the drug and are killed due to the action of drug’s cytotoxic payload. OXS-1550 has demonstrated success in early human clinical trials in patients with relapsed/refractory B-cell lymphoma or leukemia. OXS-4235 is a small molecule therapeutic candidate targeting the treatment of multiple myeloma and associated osteolytic lesions. In in vitro and in vivo models of multiple myeloma and osteoporosis, OXS-4235 demonstrated the ability to kill multiple myeloma cells, and decrease osteolytic lesions in bone. OXIS’ lead drug candidate, OXS-2175, is a small molecule therapeutic candidate targeting the treatment of triple-negative breast cancer (TNBC). In in vitro and in vivo models of TNBC, OXS-2175 demonstrated the ability to inhibit metastasis.

FORWARD LOOKING STATEMENTS – Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company’s ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company’s filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Company website: www.oxis.com

SOURCE: Oxis International, Inc.

ReleaseID: 444436

Nephros Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference

RIVER EDGE, NJ / ACCESSWIRE / August 29, 2016 / Nephros, Inc. (OTCQB: NEPH) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (“HD”) machine for the treatment of patients with end stage renal disease (“ESRD”), today announced it will be featured as a presenting company at the 18th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on September 11-13, 2016, at Lotte New York Palace Hotel in New York City.

Daron Evans, President and CEO of Nephros, will provide an overview of the Company’s business during the live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.

If you are an institutional investor, and would like to attend the Company’s presentation, please click on the following link (www.rodmanevents.com) to register for the Rodman & Renshaw conference. Once your registration is confirmed, you will be prompted to log into the conference website to request a one-on-one meeting with the Company.

Event: 18th Annual Rodman & Renshaw Global Investment Conference

Date: September 13, 2016

Time: 4:15 (Eastern Time)

Location: The Louis Room; Lotte New York Palace Hotel in New York City

About Nephros, Inc.

Nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters, as well as a hemodiafiltration system for the treatment of patients with End Stage Renal Disease. Its ultrafilters are used primarily in medical applications. Nephros ultrafilters are used by dialysis centers for the removal of biological contaminants from the water and bicarbonate concentrate feeding hemodialysis devices. In the hospital setting, Nephros ultrafilters are used as an aid in infection control by retaining bacteria (i.e. Legionella, Pseudomonas), virus and endotoxin from water used by patients. Nephros ultrafilters are also available for a number of industrial, food service, commercial and military applications.

For more information about Nephros, please visit the company’s website at www.nephros.com.

Contact:

Investor:
PCG Advisory Group
Kirin M. Smith, Chief Operating Officer
Direct: 646-863-6519
www.pcgadvisory.com

SOURCE: Nephros, Inc.

ReleaseID: 444331

Mayor Garcetti Appoints Real Estate Investment Advisor, Robert Vinson, Elected President by Commission to Oversee $25 Million Plan

Robert Vinson, a Los Angeles real estate investment advisor explains what he believes influenced a recent decision by the El Pueblo de Los Angeles Commission to elect him as President of this prestigious office after being directly appointed by Los Angeles City Mayor, Eric Garcetti.

Los Angeles, United States – August 29, 2016 /MarketersMedia/ —

An immense responsibility comes with holding any public office. Add to that, shouldering the responsibility of effectively managing a more than $25 million dollar plan in the second largest city in the U.S., and you will understand why Mayor Eric Garcetti chose Robert Vinson.

Robert Vinson, a Los Angeles real estate investment advisor to international investors, and a second generation Angelino was recently elected to the office of President after a unanimous vote by the Los Angeles City Council. “He’s sharp, knowledgeable, and hardworking,” explained Paul Koretz, an esteemed member of the Los Angeles City Council. Vinson was appointed to the Commission by a long-time supporter, Los Angeles City Mayor, Eric Garcetti. In a speech Garcetti delivered to a private gathering of friends and colleagues, he praised Vinson for the impact he has made with the City of Los Angeles over the past couple of decades. “Thank you for your incredible contribution to this city…you’re a remarkable human being and friend,” said Garcetti.

When asked why he believes Garcetti appointed him to office, Robert replied, “The Mayor and I share a passion for community service, social justice and in particular, affordable housing.” Vinson first met Garcetti in 1995 while he was a principal with Mekeel-Vinson, the builders behind the successful Tupper-Tobias Village, 28 single family homes mostly aimed at helping single moms who were first-time home buyers. At that time, Vinson was building affordable single family housing and community facilities throughout Los Angeles. He also built a Head Start Day Care Center which was later given to the City of Los Angeles.

An honors graduate and alumni of the University of Southern California, Vinson has delivered lectures at USC under their L.A. Semester Program. He’s also been endorsed by L.A. Weekly, La Opinión, and The National Organization for Women. “I believe all of this influenced the Mayor’s decision and I think the other reason is –I really know L.A.,” exclaimed Vinson. He continued, “I’m very active locally in the Southern California Association of Nonprofit Housing, Alternative Living for The Aging, where I served as Vice President to the Board, I was appointed to the California State Criminal Advisory Commission and to the State Export Finance Board by the Former Speaker of the Assembly, Antonio Villaraigosa, Mayor Garcetti’s predecessor.” Vinson has also been involved with the Urban Land Institute, co-founded L.A.’s Best Friends, a young professionals fund-raising group for the Mayor’s official charity, L.A.’s Best, and has been an active member of the advisory board for the Los Angeles Alliance for A New Economy (LAANE) for over seven years.

In 2000, Vinson founded Vinson Real Estate Group, a real estate brokerage and international business development advisory. Vinson and his firm have become the de facto advisory to international investors for real estate investment in Los Angeles. “We’ve done quite a bit outside the Unites States and we always have lots of people who are looking to establish a relationship with the city (Los Angeles) and Robert is the only one we ever refer our people to. Robert is one of the few honest and trustworthy people in the business,” said Larry Namer, Founder of E!: Entertainment Television in Los Angeles. When asked why he feels international investors looking to make sizable investments in Los Angeles seek his counsel, Vinson responded, “I’m able to provide services that other real estate brokers and advisors can’t. When you’re dealing with investors looking for exclusive or iconic properties, it’s important that they are dealing with somebody that has established ties with local government so they can more easily navigate the bureaucracy. My experience spans over two and half decades as a developer and builder so I know the entire process they’ll be going through and I can help them get over any hurdle they may face.”

Vinson encourages international investors making any sizable investment in Los Angeles to make certain the professional they choose to work with is licensed by the State of California, has the necessary years of experience and the knowledge to navigate the complex laws surrounding real estate and entitlements of land. “It goes well beyond even zoning and conditional use permits and can become incredibly litigious very quickly if you choose the wrong advisor,” explained Vinson.

Robert Vinson is a seasoned developer, builder, and advisor to international investors. He is the founder of Los Angeles-based Vinson Real Estate Group, a real estate brokerage and international business development advisory. He is also the author of the forthcoming book, The Smart Side of Mulholland Drive: 7 Things International Investors Need To Know Before Investing In Los Angeles.

For more information, please visit http://www.VinsonRealEstateGroup.com

Contact Info:
Name: Robert Vinson
Email: info@vinsonrealestategroup.com
Organization: Vinson Real Estate Group
Address: 6316 Topanga Canyon, Suite 2140, Los Angeles, CA 91367
Phone: (818) 716-6600

Source: http://marketersmedia.com/mayor-garcetti-appoints-real-estate-investment-advisor-robert-vinson-elected-president-by-commission-to-oversee-25-million-plan/129884

Release ID: 129884

Research on Global Phytosterols Market Analysis, Size, Share, Growth, Industry Trends and Forecasts to 2020 | Hexa Research

Increasing demand for herbs and minerals extracts to be reinforced as food additives in beverages and foods are anticipated to spur the “phytosterols market” growth over the forecast period.

Felton, United States – August 29, 2016 /MarketersMedia/ —

Growing awareness among consumers towards nutrients and vitamins containing food is expected to fuel the global phytosterols market growth over the next five years. Increasing demand for herbs and minerals extracts to be reinforced as food additives in beverages and foods are anticipated to spur the market growth over the forecast period. Phytosterols are steroid compounds derived from plants and have similar characteristics as cholesterol such as structural behavior and functionality. Phytosterols compete with cholesterols to reduce their level and helps to restrict absorption in digestive system. They find applications in food additives in cold cuts, spicy sauces, milk sausages, yoghurts, spreads, bakery products and margarines. Government affirmation regarding phytosterols application as food additives to supplement the nutritional requirement in foods and beverages is expected to drive the global market growth over the next five years. Growing cardiovascular diseases ad heart attacks due to high cholesterol content is anticipated to shift consumers towards phytosterols content foods. This also expected to replace cholesterol market with phytosterol in the near future. However this is a challenge to shift prospect’s mind towards phytosterol usage owing to less awareness for the product. Other similar products are also projected to hinder the global market as substitutes to the product.

Major phytosterols applications include food ingredients, pharmaceutical and cosmetics industries. Food ingredient dominated the global application market in the recent past and is expected to witness the same trend over the next five years owing to growing consumption of nutritional foods and beverages worldwide. Rising purchasing power of consumers particularly in emerging countries is expected to create huge market scope over the foreseeable future. Pharmaceutical industry followed food ingredient industry and contributed to second major market. Cosmetic industry has niche application market as compared to other two.

Phytosterols market is segmented on the basis of products into stigmesterol, campesterol, ergosterol, beta-sitosterol and brassicasterols. All these phytosterols are found in fruits, seeds, vegetables and nuts. Beta-sitosterol has vital range of applications in medical industry such as colon cancer prevention, shin problems and cervical cancer. Capesterol is collected from various plants for medical applications. Various levels of campesterols have different effects on different individuals. Even high phytosterol amount in the body is responsible for cardiovascular problems. Stigmasterol is used to manufacture semisynthetic progesterone, is a hormone required by human body to rebuild body tissues regarding estrogen effects. It is also an intermediate androgens, estrogens and corticoids biosynthesis process. Ergosterol occurs in fungal grows upon the plants due to exposure to ultra violet which transforms it into vitamin D2 that helps in bones development. It majorly finds applications in food ingredients and medical industry. Brassicasterol occurs in terrestrial plants such as oilseed rape and algae (unicellular phytoplankton). Beta-sitosterol was the leading product segment in the market in the recent past followed by campesterol. Innovation regarding product development is anticipated to provide more applications over the next five years.

Browse Related Category Market Report @

Oleoresins Market

Prebiotics Market

Europe dominated the global market followed by North America in 2013. Government favorable support regarding phytosterol usage as food additives and in medical industry is projected to spur the market over the forecast period. Asia Pacific is expected to be the emerging market on account of less awareness towards the product. However, rising purchasing power of consumers and shift in general population lifestyle particularly in emerging economies such as Indonesia, India and China is expected to fuel the market growth over the next five years.

Global phytosterol market is concentrated in nature due to top four companies contributed for more than half of the market. The market is oligopolistic owing acquisitions and mergers of several companies by major participants. The key players in the market include Cognis-BASF, Archer Daniels Midland Company, Fobes Medi-Tech, Triple Crown, Raisio Life Sciences, Arbois, Teriaka Ltd, K-Patel Phyto Extracts and Fenchem Enterprises Ltd.

About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

For more information, please visit http://www.hexaresearch.com/research-report/phytosterols-industry/

Contact Info:
Name: Michelle
Organization: Hexa Research
Address: Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States
Phone: +1-800-489-3075

Source: http://marketersmedia.com/research-on-global-phytosterols-market-analysis-size-share-growth-industry-trends-and-forecasts-to-2020-hexa-research/129988

Release ID: 129988

Wake Up Lean Review Reveals Meredith Shirk’s Overnight Belly Fat Loss Trick

Meredith Shirk’s “Wake Up Lean” course helps people take a load off unwanted stubborn pounds by teaching them a 13 second long food trick which prevents their body from storing overmuch body fat.

Dallas, TX, United States – August 29, 2016 /MarketersMedia/ —

Wake Up Lean reprograms a person’s metabolic rate. It teaches people about the three main foods that they should stave off from as they trigger the enzymes and make blood vessel burnout more evident.

Wake Up Lean is a newly launched fitness course which teaches people how dieting activates their stress sensors and hurts their metabolic rate. Strictly holding down calories averts a person’s body from burning excess stubborn fat stores effectively, meaning that weight loss impedes.

MUST WATCH: Do This ONE Trick Today To Look 1 Pound Lighter Tomorrow Morning

When a person’s body goes into starvation mode, the body becomes capable at making the most of the calories it does get from food. This leads to a loss of muscle which in turn marks down metabolic rate so that the body needs lesser calories to keep ticking over and weight loss sets back. This program teaches people that when they have crash dieted many times and strictly held down their calorie intake, they will have a lot less muscle now compared with the very first time they dieted.

Correspondingly, it’s likely that a person’s metabolic rate will also be decreased so that they need lesser calories to maintain their current weight. It also teaches people that weight regain is all in all a common occurrence amongst those who are successful at initially taking a load off unwanted body weight, however often that is due to a shift back to their old unhealthy lifestyle and diet habits.

Sometimes, it is due to the metabolic adaptations that turn up during the diet process. This weight-control program contains methods to promote feelings of fullness and nourishment. When a person’s body is nourished and when it feels full, they will be able to keep their metabolic rate high enough for potent weight loss results.

Click Here To Download The Complete Wake Up Lean PDF Guide by Meredith Shirk

This weight loss program talks about a problem which prevents a person’s body from burning excess fat as they get older which is known as The Blood Vessel Burnout. The program not only identifies this problem as one of the primary causes that a person’s body stores fat around the abdomen but it also teaches them how to overcome this issue through improved metabolism and higher circulation levels.

Furthermore, Wake Up Lean teaches people about the three main foods that they should completely stave off from. These foods are the ones which trigger the enzymes and make blood vessel burnout more noticeable. In addition, the program comes with the 13 second food trick which helps averts a person’s body from storing overmuch fat.

For more information, visit the official website here: www.wakeuplean.com

This trick works to reprogram a person’s metabolic rate so that their body automatically focuses on their waistline for energy. In doing so, their body burns overflow fat in just the right area for a leaner and stronger body. Additionally, the program comes with Wake Up Lean 10-Day Flat Belly Blueprint, 5-Minute Lean Body Bursts, and Wake Up 1 Pound Lighter 24-Hour Flushing Protocol.

For more information, please visit http://thehealthdiaries.com/wakeuplean/

Contact Info:
Name: Fara Linden
Organization: Wake Up Lean

Source: http://marketersmedia.com/wake-up-lean-review-reveals-meredith-shirks-overnight-belly-fat-loss-trick/129992

Release ID: 129992

Automotive Adhesive Tapes Market To Witness Enhanced Demand In Noise, Vibration & Masking Applications Till 2024: Grand View Research, Inc.

According to report published by Grand View Research, Inc., global automotive adhesive tapes market is expected to reach $11.54 billion by 2024, market demand was 5,745.8 million square meters in 2015 and is expected to show high gains in light of growing vehicle production.

San Francisco, California, United States – August 29, 2016 /MarketersMedia/ —

The global automotive adhesive tapes market is expected to reach USD11.54 billion by 2024, according to a new report by Grand View Research, Inc. Rising demand for adhesive tapes in an extensive range of applications including noise, vibration, masking, electrical insulation, wire harnessing, device insulation, surface protection, labeling, auto body repairs, and automotive dash will fuel industry growth over the forecast period. Replacement of fasteners by automotive adhesive tapes coupled with the introduction of new environment-friendly products will propel the market growth.
Polyvinyl chloride (PVC) was the largest segment and accounted for 31.4% of the overall volume in 2015 and is expected to witness significant rise on account of superior properties including excellent bonding, high adhesion, water resistant and good adhesion to metals. Increasing demand for lamination, insulation, protection and masking of automotive wires will propel industry expansion over the forecast period.
Double-sided tapes are expected to witness significant volume rise at a CAGR of 6.6% from 2016 to 2024 as on account of its durability, reliability, and sufficient bonding & fixing properties. Furthermore, increasing applications in automotive interior parts in light of better resistance and excellent tacky ability will promote industry expansion over the forecast period.

Access full research report: http://www.grandviewresearch.com/industry-analysis/automotive-adhesive-tapes-market
Key findings

• The global market demand was 5,745.8 million square meters in 2015 and is expected to show high gains in light of growing vehicle production in China, India, and Mexico
• Natural rubber was a prominent segment and accounted for 28.1% of the overall revenue. The product will show growth in light of superior properties including high flexibility, and versatility, and high adhesion.
• North America accounted for over 20% of the global volume share and is expected to witness significant gains in light of robust manufacturing base and rapid growth of the automotive sector in the U.S. and Mexico. National policies promoting the development of vehicles, fuel efficiency, and green policy will also impact future automotive trends. Moreover, the presence of various manufacturers including Dow Company, 3M Automotive, and PPG Automotive will augment growth.
• Latin America is expected to witness significant revenue growth at a CAGR of 7.3% from 2016 to 2024 as a result of increasing automotive vehicle sales in Argentina, Brazil, and Columbia. Increasing foreign investment in the automotive sector in the region is expected to open new market avenues over the next eight years.
• Automotive adhesive tapes industry is dominated by key participants including 3M, Tesa SE, Lintec, and Nitto Denko Corporation. Ongoing product development by various companies to manufacture high-performance and cost-efficient adhesive tapes is expected to augment product consumption over the forecast period.
• In August 2015, Shurtape launched FP 115 high-performance flatback paper tape to offer moisture resistance and stronghold for the tube, paper, and core manufacturing. In July 2014, Shurtape expanded its line of double-coated tapes with the introduction of DP 401 polyester film tape designed for polyethylene foam fabrication and lamination processes.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/plastics-polymers-and-resins

Market Segments:

Adhesive Type Outlook (Volume, Million Square Meters; Revenue, USD Million, 2013 – 2024)
• Acrylic
• Natural rubber
• Butyl
• Others
Tapes Backing Material Outlook (Volume, Million Square Meters; Revenue, USD Million, 2013 – 2024)
• Polypropylene
• Paper
• Cloth
• Foam
• PVC
• Others
Product Outlook (Volume, Million Square Meters; Revenue, USD Million, 2013 – 2024)
• Masking tapes
• Double-sided tapes
• Reinforced tapes
• Specialty tapes
Application Outlook (Volume, Million Square Meters; Revenue, USD Million, 2013 – 2024)
• Interior
• Exterior
Regional Outlook (Volume, Million Square Meters; Revenue, USD Million, 2013 – 2024)
• North America
• U.S.
• Europe
• Germany
• Asia Pacific
• China
• India
• Latin America
• Brazil
• MEA

Access press release of this research report: http://www.grandviewresearch.com/press-release/global-automotive-adhesive-tapes-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

For more information, please visit http://www.grandviewresearch.com/industry-analysis/automotive-adhesive-tapes-market

Contact Info:
Name: Sherry James
Email: sales@grandviewresearch.com
Organization: Grand View Research, Inc.
Address: 28 2nd Street, Suite 3036, San Francisco, California, 94105
Phone: 1-415-349-0058

Source: http://marketersmedia.com/automotive-adhesive-tapes-market-to-witness-enhanced-demand-in-noise-vibration-masking-applications-till-2024-grand-view-research-inc/129993

Release ID: 129993

Nano Disc Manson Hot Air Engine – By Kontax Engineering is Officially Announced

The Innovative Engine is Powered by Heat Created from the Combustion of Denatured Alcohol

LOS ANGELES, CA / ACCESSWIRE / August 29, 2016 / The founders of Kontax Engineering Ltd., a company that was formed in England in 1964, are pleased to announce the launch of the Nano Disc Manson Hot Air Engine – by Kontax Engineering.

To watch a short video on how the new hot air engine works, as well as learn more about the Kontax Engineering company, please visit https://goo.gl/kCTOF6.

As a company spokesperson noted, the Nano Disc Manson Hot Air Engine has a distinctive soft hum that is reminiscent of a film projector. The innovative engine is powered by heat that is created from the combustion of denatured alcohol, otherwise known as methylated spirits.

Kontax’s engineering team used the Manson engine prototype to create this small engine, which makes for an attractive display piece or entrancing educational model.

“Since 2001 we have been well known for making various types of high quality Stirling engines,” noted the spokesperson, adding that this time, they decided to venture away from Stirling engines and develop a Manson engine.

“Our design approach for this engine has been the same as for all our engines, which is to fully design and simulate the mechanism in CAD before making any parts. Prototypes then get made and tested, small adjustment are made, new parts designed, made and re-tested until the engine is perfected. From the first prototype to the last prototype a huge increase in performance was achieved.”

While a Manson engine is similar to a Stirling engine, the spokesperson said there are two major differences. For example, the Manson draws in and expels air, and it is able to have a single connecting rod so the displacer piston and power piston are on the same shaft and move at the same time.

To help pay for the production costs associated with creating the new Nano Disc Manson Hot Air Engine, Kontax Engineering recently launched a fundraiser on Kickstarter. To learn more about the professional and talented team behind this innovative engine, people may check out the campaign page at any time.

About the Nano Disc Manson Hot Air Engine:

Kontax Engineering is working on developing and releasing the Nano Disc Manson Hot Air Engine. The engine is powered by heat that is created from combustion of denatured alcohol. The engine can be used as an interesting display piece or to help educate students. For more information, please visit https://goo.gl/kCTOF6.

Contact:

Allan Austin
admin@rocketfactor.com
(949) 555-2861

SOURCE: Nano Disc Manson Hot Air Engine

ReleaseID: 444435

Breast Biopsy Device Market Is Projected To Grow 12.6% CAGR In Asia Pacific Region Till 2024: Grand View Research, Inc.

According to report published by Grand View Research, Inc., global breast biopsy device market will reach $911.2 million by 2024, rising awareness levels with regard to diagnostic procedures through cancer screening programs, rise in breast cancers in women, and the high demand for less-invasive procedures.

San Francisco, California, United States – August 29, 2016 /MarketersMedia/ —

The breast biopsy device market is expected to reach USD 911.2 million by 2024, according to a new report by Grand View Research, Inc. The Breast biopsy device market is projected to grow at a productive rate in the next few years. The key factors supporting the industry’s growth involve the rising awareness levels with regard to diagnostic procedures through cancer screening programs, global rise in breast cancers in women, and the high demand for less-invasive procedures. However, the degree of risk is directly proportional to the extent of procedure invasiveness. Biopsy causes pain and is a stressful procedure for patients, moreover, approximately 60% to 80% of breast biopsies in women result in a benign judgment. Therefore, women are encouraged to consult experts for a second opinion before undergoing a biopsy procedure, which is likely to hinder the growth of the market.
The test type segment is categorized into needle breast biopsies and open surgical biopsies. The former is further segmented into fine-needle aspiration, core-needle, and vacuum-assisted core biopsy. The fine-needle aspiration segment is estimated to hold the largest share for the year 2015 whereas the vacuum-assisted core biopsy segment is anticipated to witness a lucrative growth during the study period. The open surgical biopsy industry is sub-segmented into Incisional biopsy and Excisional biopsy.
On the basis of products, the industry is categorized into needles, tables, localization wires, and guidance systems. Additionally, the guidance systems segment of the industry is further categorized on the basis of imaging systems, such as ultrasound, mammography, and magnetic resonance imaging.

Access full research report: http://www.grandviewresearch.com/industry-analysis/breast-biopsy-device-market

Key findings

• The Asia Pacific region is anticipated to witness the highest growth rate, with a CAGR of around 12.6% during the forecast period. The high frequencies of breast cancer prevailing in women as well as the increase in awareness of cancer screening programs are the factors fueling the market growth.
• North America accounts for the largest market share, followed by the European market. The heightened awareness about breast cancer that advocate regular checkups and screening programs along with the demand for accurate and minimally caustic procedures are factors that are responsible for the rapid market growth.
• The mammography-guided stereotactic segment is estimated to hold the largest market share followed by the magnetic resonance imaging-guided category. The rise in demand for rapid and precise diagnostic imaging tools in determining the exact location of the tumor or lump in the breast area is one of the major factors driving the growth of this industry
• On the basis of test type, the needle-based biopsy segment accounts for the largest share; this is mainly due to the high demand for minimally invasive procedures. On the other hand, the open surgical biopsies have a probability to witness a decline in the market over the next few years due to the relatively high invasiveness and the risks involved with the procedure.
• Some major players in this industry include Becton, Dickenson and Company (BD),C.R Bard, Inc., Devicor medical, Inc., and Hologic, Inc., among others.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Market Segments:

Breast Biopsy Devices Market By Test Type Outlook (Revenue, USD Million, 2013 – 2024)
• Needle breast biopsies
• Fine-needle aspiration
• Core-needle aspiration
• Vacuum-assisted core biopsy
• Open surgical biopsies
• Incisional breast biopsy
• Excisional breast biopsy
Breast Biopsy Devices Market By Product Outlook (Revenue, USD Million, 2013 – 2024)
• Biopsy needles
• Biopsy tables
• Localization wires
• Guidance systems
• Others
Breast Biopsy Devices Market By Guidance Type Outlook (Revenue, USD Million, 2013 – 2024)
• Ultrasound-guided
• Mammography-guided stereotactic
• Magnetic resonance-guided
• Others
Breast biopsy device market Regional Outlook (Revenue, USD Million, 2013 – 2024)
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Asia Pacific
• China
• India
• Latin America
• Brazil
• Mexico
• Middle East and Africa
• South Africa

Access press release of this research report: http://www.grandviewresearch.com/press-release/global-breast-biopsy-device-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

For more information, please visit http://www.grandviewresearch.com/industry-analysis/breast-biopsy-device-market

Contact Info:
Name: Sherry James
Email: sales@grandviewresearch.com
Organization: Grand View Research, Inc.
Address: 28 2nd Street, Suite 3036, San Francisco, California, 94105
Phone: 1-415-349-0058

Source: http://marketersmedia.com/breast-biopsy-device-market-is-projected-to-grow-12-6-cagr-in-asia-pacific-region-till-2024-grand-view-research-inc/129999

Release ID: 129999

Through My Lens is a New Movement That Helps People with Disabilities Create Films

Through My Lens will teach students with disabilities how to express themselves through video

LOS ANGELES, CA / ACCESSWIRE / August 29, 2016 / Reid Davenport and Dan Lee are proud to announce their new film-based movement called “Through my Lens.”

To learn more about Through my Lens, please visit: https://goo.gl/C2C2Kt

The project was started by Reid and Dan as a way to bring awareness to the general public about disabilities. By encouraging disabled and non-disabled filmmakers to create films from the perspective of handicap men and women, they hope to tap into the ever increasing popularity of film as a medium to educate.

“Dan and Reid have known each other since the 3rd grade,” says the website. “Growing up in a small town in Connecticut, they have remained best friends since leaving for college and following their own career paths.”

Today, Reid is a graduate from Stanford University with a Master’s degree in Documentary Film and Video, and spends his time speaking at schools in an initial effort to educate the public about what it’s like to have a disability. His films have been shown across the country and around the world, and have gained prominent media attention from NPR, BBC and the Washington Post.

Dan is a disability advocate, and has been selflessly volunteering for organizations since middle school.

Together they hope to take their project on the road and produce a pilot at a school or University during the winter/spring semester of 2017.

In order to supplement the funds needed to produce their pilot, the duo has taken their project to the pages of Indiegogo. Sponsors will enjoy a number of perks including mention in their pilot series, their name featured on their website, a video appearance in the pilot, or even a personal visit by Dan and Reid to produce the pilot itself.

“Help us get the ball rolling so we can do a pilot at a school or university during the winter/spring semester of 2017. Your contributions will go towards travel costs, equipment for students, camera people to document the pilot, and more,” says the website.

About Through my Lens:

Through my Lens is a film-based movement which will bring more awareness to the plight of disabled individuals. By taking their campaign to schools and Universities, Reid Davenport and Dan Lee will educate students from a handicap person’s perspective, and encourage students with disabilities to express themselves through the medium of film.

Contact:

Debbie Morton
admin@rocketfactor.com
(949) 555-2861

SOURCE: Through my Lens

ReleaseID: 444434